Table 3.
Variable | Duration | Groups | Comparison | |
---|---|---|---|---|
Mean differences | P Value | |||
Osteoblast | 2-weeks | C/GS | −5.12 | 0.0001∗∗ |
C/[GS/PSO] | −9.97 | 0.0001∗∗ | ||
GS/[GS/PSO] | −4.86 | 0.0001∗∗ | ||
4-weeks | C/GS | −4.34 | 0.0001∗∗ | |
C/[GS/PSO] | −8.46 | 0.0001∗∗ | ||
GS/[GS/PSO] | −4.12 | 0.0001∗∗ | ||
| ||||
Osteocyte | 2-weeks | C/GS | −3.8 | 0.0001∗∗ |
C/[GS/PSO] | −9.02 | 0.0001∗∗ | ||
GS/[GS/PSO] | −5.22 | 0.0001∗∗ | ||
4-weeks | C/GS | −5.41 | 0.005∗ | |
C/[GS/PSO] | −9.78 | 0.0001∗∗ | ||
GS/[GS/PSO] | −4.37 | 0.0001∗∗ | ||
| ||||
Osteoclast | 2-weeks | C/GS | 0.343 | 0.002∗ |
C/[GS/PSO] | 0.484 | 0.001∗∗ | ||
GS/[GS/PSO] | 0.241 | 0.002∗ | ||
4-weeks | C/GS | 0.09 | 0.030∗ | |
C/[GS/PSO] | 0.19 | 0.0001∗∗ | ||
GS/[GS/PSO] | 0.1 | 0.032∗ |
∗ significant (P > 0.05), ∗∗high significant (P ≤ 0.001).